Kanso Diagnostics
Kanso Diagnostics
Agent28Agent Readiness: 28/100. Bottom 25%. Measured by StartupHub.ai. Median 41.Develops a proprietary, stand-alone platform for rapid, lab-grade molecular diagnostics at the point of need.
About
We strive for a modern diagnostics experience, suitable for today’s at-home medical revolution, accessible for all and easy to use. Our novel platform can accurately detect multiple pathogens and genetic biomarkers from a single sample. It can reduce diagnosis time-to-results from days to minutes.
Key facts
At-a-glance profile data
- Website
- kansodx.com
- Headquarters
- Or Yehuda, Israel
- Founded
- 2021
- Employees
- 7
- Total funding
- -
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 20 Nov 2023 | Seed | Undisclosed | - |
Tech stack
Detected on kansodx.com, last scanned 27 Sept 2026. Run your own scan
- CDN
- Netlify
- Email provider
- Google Workspace
Add first review
Frequently asked
What does Kanso Diagnostics do?
Our proprietary technology offers PCR grade accuracy with rapid home testing conveniency, enabling an end-to-end solution for diagnosis of bacterial and viral infections anywhere and anytime.
How many employees does Kanso Diagnostics have?
Kanso Diagnostics has approximately 7 people on record.